Home/Filings/4/0001209191-23-019791
4//SEC Filing

Tada Hiroomi 4

Accession 0001209191-23-019791

CIK 0001863127other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 5:27 PM ET

Size

4.6 KB

Accession

0001209191-23-019791

Insider Transaction Report

Form 4
Period: 2023-03-15
Tada Hiroomi
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-03-15$6.58/sh+1,893$12,45483,130 total
Footnotes (1)
  • [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001880593

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:27 PM ET
Size
4.6 KB